TY - EJOU AU - Taylor, Zachariah AU - Meyer, Kayla AU - Terrenzio, Danielle AU - Wong, Ryan AU - Larson, Sharon AU - Kjelstrom, Stephanie AU - Contoreggi, Natalina AU - Belkoff, Laurence AU - Zeltser, Ilia TI - Mind matters: how anxiety and depression shape low-risk prostate cancer active surveillance adherence in a real-world population T2 - Canadian Journal of Urology PY - 2025 VL - 32 IS - 1 SN - 1488-5581 AB - Purpose: While the mental health impact of a prostate cancer diagnosis, including low-risk prostate cancer, is well-documented, the effect of pre-existing anxiety and/or depression on adherence to active surveillance protocols in low-risk prostate cancer patients remains unclear. This study assessed the association between prior anxiety and/or depression and active surveillance adherence in men with low-risk prostate cancer. Methods: We conducted a retrospective, multicenter study involving 426 men diagnosed with low-risk prostate cancer who were recommended active surveillance as the primary management strategy. Active surveillance adherence was defined by completion of both a prostate-specific antigen test and a prostate biopsy within 18 months of diagnosis. Premature treatment was identified as definitive treatment, either through radiation therapy or radical prostatectomy. Results: Men with a prior mental health diagnosis were significantly less likely to adhere to active surveillance than those without such a diagnosis (27.6% vs. 49.5%, p = 0.006). These individuals had lower adherence rates for prostate-specific testing (58.6% vs. 73.4%) and biopsy (27.6% vs. 50.0%) and were more likely to abandon active surveillance in favor of immediate treatment (39.7% vs. 25.0%, p = 0.005). No significant differences were observed between patients with both anxiety and depression versus those with a single diagnosis. Conclusions: Pre-existing anxiety and/or depression is associated with reduced active surveillance adherence and a greater likelihood of premature treatment in men with low-risk prostate cancer. These findings highlight the importance of addressing psychiatric factors in low-risk prostate cancer management and suggest avenues for future research. KW - anxiety; depression; active surveillance; low-risk prostate cancer DO - 10.32604/cju.2025.064705